289 filings
20-F
2023 FY
CMMB
Chemomab Therapeutics Ltd
Annual report (foreign)
28 Mar 24
6:03am
SC 13D/A
OrbiMed Israel BioFund GP Limited Partnership
11 Mar 24
Chemomab Therapeutics / OrbiMed Israel BioFund GP Limited Partnership ownership change
7:19pm
6-K
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
SC 13D/A
OrbiMed Israel BioFund GP Limited Partnership
15 Nov 23
Chemomab Therapeutics / OrbiMed Israel BioFund GP Limited Partnership ownership change
4:35pm
6-K
a5ysvi0h9qum xkjm
9 Nov 23
Current report (foreign)
8:00am
EFFECT
d21ybk cnd81
6 Nov 23
Notice of effectiveness
12:15am
CORRESP
1pmu8y2abfm
1 Nov 23
Correspondence with SEC
12:00am
F-3/A
7zkt8mi9
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
p9hk62os3v9xrc
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
feo8xsa2bwb4
14 Aug 23
Current report (foreign)
8:05am
6-K
8boscmt72vkpo6k7 46
8 Aug 23
Current report (foreign)
6:00am
4
9i5ezyovarrygijhjdn4
5 Jul 23
Chemomab Therapeutics / Nissim Darvish ownership change
5:48pm
6-K
f10moukf9e
3 Jul 23
Current report (foreign)
3:49pm
4
jkjr77
20 Jun 23
Chemomab Therapeutics / Jill M. Quigley ownership change
6:03am
4
25a6wn80
16 Jun 23
Chemomab Therapeutics / Sigal Fatal ownership change
4:03pm
8-K
kqnsj66b6q
16 Jun 23
Departure of Directors or Certain Officers
4:01pm
3
w1u 7q7s12u
5 Jun 23
Chemomab Therapeutics / Sigal Fatal ownership change
4:54pm
8-K
hf81cdo6bkbv4 56
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
RW
079r8csnz2lk6hxj
2 Jun 23
Registration withdrawal request
4:02pm